Are you an experienced clinician or scientist with clinical research experience in either immunology & autoimmune disease gastrointestinal respiratory disease cell therapy or cardiorenal and metabolism-related diseases Would you like to be part of a talented and high performing team of clinical research professionals clinical scientists and physicians who are translating rigorous scientific discoveries into early or late phase clinical development plans and studies across a wide range of chronic and debilitating diseases
The AstraZeneca BioPharma Fellows Program is a competitive 12-month immersive research and training program in clinical development for early-career physicians and scientists who are inspired by science and by how clinical development has the potential to transform patient care. As part of the selected cohort of fellows youll have an opportunity to learn from a diverse group of experts across the drug development continuum and play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients lives. We are currently recruiting the 2026 fellowship cohort for a summer 2026 start.
This is an office-based role that is located at AstraZenecas vibrant R&D site in Boston (Seaport Blvd) Massachusetts in the United States transferring to our purpose-built facility in Kendall Square once it opens in 2026.
At AstraZeneca were dedicated to being a Great Place to Work with an inclusive and diverse team who work in a solution-oriented trusting and collaborative work environment. Were pushing the boundaries of science to deliver life-changing medicines to patients with a passion for discovery and a pipeline to show for it. We are dedicated to improving the health care and quality of life for patients across a wide range of diseases and disorders by developing innovative therapies that address unmet clinical needs and provide clinicians with novel evidence-based treatment options to optimize the care of their patients.
Who we Are
In the Respiratory and Immunology (R&I) Late Clinical Development team we are investigating the novel and advanced science of R&I diseases to deliver life-changing medicines to patients. Our ambition is to pioneer innovative research and explore novel therapeutic pipelines to become the worldwide leading company in immunology. With such passion our portfolio includes various gastrointestinal rheumatology dermatology immunology and respiratory diseases.
In Immunology Cell Therapy we are advancing our growing ambition in immunology by driving next-generation cell therapies (including CAR-T cells and other modalities) with the potential to restore immune tolerance and even cure immune-mediated and inflammatory diseases. Our innovative approaches and deep expertise in cell therapy give us an opportunity to deliver life-changing therapeutics to patients. This is an excellent program to provide medical and scientific input to T-cell therapy clinical stage assets working in collaboration with and learning from cross-functional teams including basic research clinical pharmacology and translational medicine clinical operations medical directors safety regulatory affairs biostatistics cell product manufacturing and commercial.
In the Cardiovascular Renal & Metabolism (CVRM) Translational Science & Early Clinical Development (TSCD) team we are investigating the drivers of CVRM disease progression through ground-breaking scientific methods and data-driven drug discovery this context we are investigating a wide range of different drug modalities from our rich CVRM portfolio of compounds across diverse metabolic patient populations including obesity T2DM and MASH.
TSCD part of the Early CVRM organization is where science meets clinical drug development with a focus upon delivering innovative early phase clinical studies and accelerating human target validation while collaborating closely with our late phase clinical development and regulatory colleagues who guide our pivotal phase 3 clinical studies. We are a diverse team of experienced physicians and clinical scientists who collaborate to delineate early phase clinical development strategies design innovative phase I-IIa clinical trials develop and validate novel surrogate endpoints and translate scientific ideas to proof-of-concept studies in targeted patient populations.
What youll do
The 2026 AstraZeneca BioPharma Fellows will join AstraZeneca at a time of tremendous growth and acceleration in the BioPharma portfolio. You will be assigned to a team in Early or Late Clinical Development for the duration of the program and spend up to 50% of your time rotating across functions concluding with a fixed placement on a development team. You will work in a fast-paced and dynamic setting with increasing responsibility following a structured learning plan across the following domains:
In addition you will participate in regular clinical and scientific meetings related to your project attend training throughout the program and engage in internal and external AstraZeneca and scientific meetings. You will serve as the lead for a longitudinal clinical project. Specific duties and major responsibilities may include any of the following:
Minimum Qualifications:
Desirable Qualifications:
So whats next
Complete your application before the below closing date.
This role is open from 11/28/2025 we invite you to apply no later than 01/15/2026.
Where can I find out more
Date Posted
28-Nov-2025Closing Date
14-Jan-2026Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and furtherance of that mission we welcome and consider applications from all qualified candidates regardless of their protected characteristics. If you have a disability or special need that requires accommodation please complete the corresponding section in the application form.
Required Experience:
Director
AstraZeneca is an equal opportunity employer. AstraZeneca will consider all qualified applicants for employment without discrimination on grounds of disability, sex or sexual orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, ... View more